FDA Inspection
AbbVie Bioresearch CenterAbbVie Bioresearch Center – FDA Inspection, Dec 16, 2025
Record Details
This FDA Inspection record concerns AbbVie Bioresearch Center, with an inspection on December 16, 2025, issued by the New England District Office, covering biologics.
View Company Profile
ID · 9cda06b1-831d-4b36-857f-63c6870cb2f2
Inspection Facts
- Inspection number
- 1295502
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of AbbVie Bioresearch Center
12| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | Not classified | New England District Office | |
| January 30, 2024 | Not classified | New England District Office | |
| November 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 11, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AbbVie Bioresearch Center
- FDA Inspection 1272372 - 2025-09-05
- FDA Inspection 1252835 - 2024-01-30
- FDA Inspection 1113080 - 2019-11-18
- FDA Inspection 1056813 - 2018-05-24
- FDA Inspection 1010336 - 2017-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.